Medmark

Medmark is a drug discovery company in Lewisville, United States, founded in 2006. It has 1 recorded funding round, most recently a Growth Equity in August 2026.

Headquarters
Lewisville, Texas
Founded
2006
Business Model
B2C
Last Round
Growth EquityAug 2026
Rounds
1

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

MedMark Treatment Centers provides outpatient, medication-assisted treatment and counseling to help people recover from opioid use disorder across the United States. Since 2006, the company has helped thousands of people access effective opioid use disorder treatment and rebuild their lives. What began with three programs in Northern California has evolved into a nationwide network of over 50 treatment centers, delivering evidence-based, compassionate care that fits patients' lives and supports long-term wellness.

Summary

Its most recent funding was a Growth Equity round in Aug 2026. Investors include Phoenix Holdings.

Funding History

Data from Indexed.vcUpdated
Growth EquityGrowth EquityAug 2026
EUR 70.0M

Investors

Similar Companies

Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Shields Health Solutions

The nation's first company to integrate specialty pharmacies into hospitals and health systems, h...

United StatesHealthcare, Drug Discovery
Corporate RoundTotal funding$3.5BSep 2025
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Medmark on Indexed.vc
<a href="https://indexed.vc/companies/medmark"><img src="https://indexed.vc/api/badge/company/medmark" alt="Medmark on Indexed.vc" width="260" height="76" /></a>